In this interview, Ms Dao Thu Nga, head of Cambodia operations for one of the world’s most socially responsible pharmaceutical companies, talks about the company’s approach to healthcare in Cambodia.
“CSR has always been our main focus. One of our key priorities is access to healthcare for underserved populations,” said Ms. Dao Thu Nga, Head of Cambodia Operations for one of the world’s most socially responsible pharmaceutical companies.
To that end, Sanofi is a founding partner of the Access Accelerated Initiative, an international coalition launched to address the burden of non-communicable diseases in lower income countries with a goal to reduce premature deaths from those diseases by one third by 2030.
“Our commitment to CSR is to also illustrate our longstanding adhesion to the United Nations Global Compact as well as our contribution to the achievement of the United Nations Sustainable Development Goals.”
On Sanofi’s major CSR activities, Ms Nga said in June this year, Sanofi will be launching one of the biggest projects called Cambodia Education Program on Diabetes (CEP-D). The three-year campaign until 2020 is aimed at promoting better care and management of diabetes.
Cambodia has a high rate of diabetes cases, counted at 230,800 cases in 2015, and is expected to increase approximately by 40% in 2040. The campaign will also seek to provide training to about 1180 healthcare professionals and 500 medical students and as well the overall Cambodian population will be involved in educational and awareness raising actions.
Relevant key stakeholders such as CSDE, University of Health and Sciences, Medical Council and the Ministry of Health will be involved to ensure the effectiveness, impact and high quality of the project.
Ms Nga stressed “We strongly believe that it is important to take part in raising the awareness and providing training about the disease. New initiatives need to emerge to build on these past projects and improve the overall situation. The program will make huge positive impact toward the diabetes patients and healthcare professionals across the country.”
The project is co-financing from Sanofi and German Investment and Development Corporation DEG and in cooperation with ASSIST with nearly a half million USD budget.
On Sanofi’s CSR with company staff, she stressed that every staff is highly encouraged to join and build sharing culture through campaigns such as blood donation, World Rabies Day, World Diabetes Day, anti-counterfeit campaign, and providing healthcare training to NGOs.
“More than this, our employees are trained on good governance and compliance, code of ethics, conflict of interest, anti-corruption, pharmacovigilance and relevant programs when they first join Sanofi family.”
At Sanofi, as a global company, employees have many opportunities to expose to Sanofi internationally as the company is present in more than 100 countries. “We provide many fantastic opportunities for our employees to grow and develop themselves through our development plan, strong policy and international standard.”
Sanofi’s CSR activities are funded by the Sanofi Epsor Foundation, which was established by the Sanofi Group in October 2010 to fortify its international solidarity and make its commitment clearer to all stake-holders. The Foundation’s task is helping reduce healthcare inequalities and poverty among the world’s poorest populations. In Cambodia, the Foundation invests through the projects that meet the conditions of our call for themed projects, a field project related to healthcare, which contributes to reduce health inequalities.